BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -38.81% | 157.75% | 97.45% | 357.44% | 342.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -38.81% | 157.75% | 97.45% | 357.44% | 342.04% |
| Cost of Revenue | -19.79% | 269.06% | 192.31% | 825.47% | 673.13% |
| Gross Profit | -45.81% | 68.70% | 64.40% | 246.17% | 281.64% |
| SG&A Expenses | 52.46% | 121.36% | 91.86% | 161.13% | 62.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.57% | 188.09% | 120.63% | 319.43% | 141.78% |
| Operating Income | -153.87% | -1,667.00% | -115.66% | 516.85% | 899.25% |
| Income Before Tax | -153.87% | -1,667.00% | -115.66% | 516.85% | 899.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -153.87% | -2,436.00% | -115.66% | 516.85% | 899.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -153.87% | -2,436.00% | -115.66% | 516.85% | 899.25% |
| EBIT | -153.87% | -1,667.00% | -115.66% | 516.85% | 899.25% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -308.25% | -2,466.67% | -114.81% | 487.32% | 286.54% |
| Normalized Basic EPS | -306.56% | -1,583.33% | -114.71% | 480.00% | 290.63% |
| EPS Diluted | -308.25% | -21,400.00% | -114.81% | 463.38% | 286.54% |
| Normalized Diluted EPS | -310.00% | -1,583.33% | -115.63% | 486.36% | 287.50% |
| Average Basic Shares Outstanding | -74.09% | 1.88% | 4.82% | 5.58% | 324.39% |
| Average Diluted Shares Outstanding | -74.34% | -1.94% | 0.78% | 5.52% | 328.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |